Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953402 · ClinicalTrials.gov registry record
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
A clinical trial, sponsored by Bristol-Myers Squibb.
- Recruiting
- Registry status
- 1,182
- Enrollment target
NCT05953402: Recruiting study, sponsored by Bristol-Myers Squibb.
NCT05953402 is a clinical trial that is actively recruiting participants, run by Bristol-Myers Squibb. The registered enrollment target is 1,182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05953402 is actively recruiting participants, sponsored by Bristol-Myers Squibb.
- RECRUITING
- Registry status
- 1,182 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,182 participants |
| Start Date | 2026-04-21 |
| Est. Completion | 2034-06-30 |
What NCT05953402 shows while recruiting
NCT05953402 is an observational study that tracks outcomes without assigning an intervention. Its 1,182 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05953402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05953402 about?
NCT05953402 is a clinical study titled "A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring". The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
What is the current status of trial NCT05953402?
This trial is currently recruiting. The enrollment target is 1,182 participants. The study started on 2026-04-21. Estimated completion is 2034-06-30.
Who is sponsoring clinical trial NCT05953402?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05688436 · 1,178 participants
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- NCT06931275 · 1,178 participants · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI